Diagnostic criteria for nephrotic syndrome
Reading Document
Medical Text Search
nephrotic syndrome diagnostic criteria proteinuria hypoalbuminemia edema
Medical Text Search
nephrotic syndrome causes classification pathophysiology
GradeResponse
GradeResponse
Nephrotic Syndrome — Diagnostic Criteria
Core Diagnostic Triad
According to Harrison's Principles of Internal Medicine (21st ed., p. 8392), nephrotic syndrome (NS) is defined by three essential features:
| Feature | Threshold |
|---|---|
| Proteinuria | > 3.5 g/day (heavy, "nephrotic-range") |
| Hypoalbuminemia | Serum albumin < 3.5 g/dL |
| Edema | Peripheral, typically pitting; periorbital in children |
All three must be present for the diagnosis. In clinical practice, proteinuria > 3.5 g/day in adults (or > 40 mg/m²/hr in children) is the sine qua non.
Associated Features (Not Required but Commonly Present)
| Feature | Details |
|---|---|
| Hyperlipidemia | Elevated LDL, reduced HDL (compensatory hepatic lipoprotein synthesis) |
| Lipiduria | Oval fat bodies, fatty casts, Maltese cross appearance under polarized light |
| Hypercoagulability | Loss of antithrombin III, proteins C and S → venous thrombosis risk |
| Hypertension | Especially in secondary causes |
| Frothy urine | Due to heavy proteinuria |
Diagnostic Workup
Urine studies:
- 24-hour urine protein (gold standard) — confirms > 3.5 g/day
- Spot urine protein-to-creatinine ratio > 3.5 mg/mg (practical equivalent)
- Urinalysis: oval fat bodies, fatty/granular casts, Maltese crosses under polarized light
Serum labs:
- Albumin < 3.5 g/dL
- Lipid panel: elevated total cholesterol, LDL, triglycerides
- BMP/CMP: assess renal function (creatinine, BUN, eGFR)
- Complement levels (C3, C4): low in membranoproliferative GN, lupus nephritis
- ANA, anti-dsDNA: if lupus nephritis suspected
- Serum protein electrophoresis (SPEP): if amyloidosis or multiple myeloma considered
- Anti-PLA₂R antibody: 70% of primary membranous nephropathy cases (Harrison's, p. 8394)
- Hepatitis B/C serologies, HIV: secondary causes
Renal biopsy:
- Required in adults to determine the underlying pathologic cause
- May be deferred in children (presumptive minimal change disease treated empirically with steroids)
Causes (Primary vs. Secondary)
Primary (idiopathic) glomerulopathies:
- Minimal Change Disease (MCD) — most common in children
- Focal Segmental Glomerulosclerosis (FSGS)
- Membranous Nephropathy (MN) — most common in adults
- Membranoproliferative GN (MPGN) / C3 glomerulopathy
Secondary causes:
- Diabetes mellitus (diabetic nephropathy)
- Systemic lupus erythematosus (lupus nephritis class V)
- Amyloidosis (AL amyloid, SAA/reactive amyloidosis)
- Infections: Hepatitis B/C, HIV, malaria
- Drugs: NSAIDs, gold, penicillamine, heroin
- Malignancy: solid tumors (MN), hematologic (MCD)
Key Distinctions: Nephrotic vs. Nephritic
| Feature | Nephrotic | Nephritic |
|---|---|---|
| Proteinuria | > 3.5 g/day | < 3.5 g/day |
| Hematuria | Absent or minimal | Prominent (RBC casts) |
| Hypertension | Variable | Common |
| Edema | Prominent | Moderate |
| GFR | Usually preserved initially | Often reduced |
Sources: Harrison's Principles of Internal Medicine, 21st Edition, pp. 8392, 8394
Explain everything on nephrotic syndrome and differential diagnosis and difference between nephrotic and nephritic syndrome
Medical Text Search
nephrotic syndrome pathophysiology mechanisms proteinuria hypoalbuminemia edema hyperlipidemia
Medical Text Search
nephrotic syndrome differential diagnosis minimal change disease FSGS membranous nephropathy
GradeResponse
GradeResponse
Medical Text Search
nephritic syndrome glomerulonephritis hematuria RBC casts hypertension oliguria
Medical Text Search
minimal change disease focal segmental glomerulosclerosis membranous nephropathy treatment prognosis
Here is a comprehensive breakdown of nephrotic syndrome, its differential diagnosis, and its distinction from nephritic syndrome.
Nephrotic Syndrome — Complete Overview
1. Definition
Nephrotic syndrome is defined by the triad of:
- Proteinuria > 3.5 g/day (nephrotic-range)
- Hypoalbuminemia < 3.5 g/dL
- Edema (peripheral, periorbital)
Associated features: hyperlipidemia, lipiduria, hypercoagulability.
2. Pathophysiology
(Harrison's, p. 1376)
The central defect is loss of integrity of the glomerular filtration barrier, leading to a cascade of consequences:
A. Glomerular Filtration Barrier Disruption
The normal barrier consists of:
- Fenestrated endothelium — size selectivity
- Glomerular basement membrane (GBM) — charge and size barrier
- Podocytes (visceral epithelial cells) with foot processes — critical charge barrier (anionic coating via podocalyxin)
Injury to podocytes → foot process effacement → loss of charge selectivity → massive protein leak (predominantly albumin).
B. Hypoalbuminemia
- Urinary losses of albumin exceed hepatic synthetic capacity
- Increased proximal tubular catabolism of filtered albumin
- Hepatic synthesis is upregulated but insufficient to compensate
C. Edema Formation (Two Mechanisms)
| Mechanism | Description |
|---|---|
| Underfill hypothesis | ↓ Oncotic pressure → fluid shifts to interstitium → ↓ effective circulating volume → RAAS activation, ADH release, SNS activation → Na+ and water retention → edema |
| Overfill hypothesis | Primary renal Na+ retention (independent of oncotic changes) → volume expansion → edema |
Both mechanisms likely operate, with filtered proteases directly activating ENaC (epithelial sodium channels) in principal cells, perpetuating Na+ retention.
D. Hyperlipidemia
- ↓ Oncotic pressure → hepatic upregulation of lipoprotein synthesis (LDL, VLDL)
- ↓ Lipoprotein lipase activity → impaired clearance
- Result: ↑ total cholesterol, ↑ LDL, ↑ triglycerides, ↓ HDL
E. Lipiduria
- Lipoproteins filtered into urine → taken up by tubular cells → sloughed as oval fat bodies
- Oval fat bodies contain cholesterol crystals visible as Maltese crosses under polarized light
- Appear as fatty casts on urinalysis
F. Hypercoagulability
Urinary loss of anticoagulant proteins:
- ↓ Antithrombin III
- ↓ Protein C and Protein S
- ↓ Plasminogen
- ↑ Fibrinogen (hepatic overproduction)
- Platelet hyperaggregability
→ Risk of deep vein thrombosis, pulmonary embolism, and renal vein thrombosis (especially in membranous nephropathy)
G. Susceptibility to Infection
- Loss of immunoglobulins (IgG) and complement factors (especially Factor B) in urine
- Impaired opsonization → susceptibility to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae)
- Spontaneous bacterial peritonitis is a feared complication, especially in children
3. Clinical Features
| Feature | Details |
|---|---|
| Edema | Bilateral, dependent, pitting; periorbital (especially in children, worse in morning); ascites, pleural effusion in severe cases |
| Frothy/foamy urine | Due to proteinuria |
| Weight gain | Fluid retention |
| Anorexia, malaise | Due to hypoalbuminemia |
| Xanthomas | In chronic hyperlipidemia |
| Thromboembolism signs | Leg swelling, pleuritic chest pain, flank pain (renal vein thrombosis) |
| Infections | Recurrent, especially peritonitis |
| Hypertension | Uncommon in primary NS; more common in secondary causes |
4. Investigations
Urine
| Test | Findings |
|---|---|
| Dipstick | 3+ to 4+ protein |
| 24-hour urine protein | > 3.5 g/day |
| Spot urine PCR | > 3.5 mg/mg (protein:creatinine ratio) |
| Microscopy | Oval fat bodies, Maltese crosses, fatty casts, no/few RBC casts |
Blood
| Test | Findings |
|---|---|
| Serum albumin | < 3.5 g/dL |
| Lipid panel | ↑ Cholesterol, ↑ LDL, ↑ triglycerides |
| BMP/CMP | Creatinine, BUN, eGFR (often normal initially) |
| Complement C3/C4 | Low in MPGN, lupus nephritis; normal in MCD, MN, FSGS |
| ANA, anti-dsDNA | Lupus nephritis |
| Anti-PLA₂R | Positive in ~70% of primary membranous nephropathy |
| SPEP/UPEP | Amyloidosis, multiple myeloma |
| HBsAg, HCV Ab, HIV | Secondary causes |
| Coagulation studies | PT, aPTT, fibrinogen, antithrombin III |
Imaging
- Renal ultrasound: kidney size, echogenicity (enlarged/echogenic in acute NS)
- Doppler: renal vein thrombosis if suspected
Renal Biopsy
- Mandatory in adults to define the underlying glomerulopathy
- Deferred in children (age 1–8) with presumed MCD → empiric steroid trial first; biopsy if steroid-resistant
5. Causes and Differential Diagnosis
(Harrison's, p. 8394)
Primary (Idiopathic) Causes
| Disease | Key Features | Population | Biopsy Findings |
|---|---|---|---|
| Minimal Change Disease (MCD) | Abrupt onset, selective proteinuria (albumin only), responds to steroids, normal light microscopy | Children (most common), young adults | LM: normal; EM: diffuse foot process effacement; IF: negative |
| Focal Segmental Glomerulosclerosis (FSGS) | Non-selective proteinuria, hypertension, hematuria possible, steroid-resistant forms | Adolescents, young adults, Black patients, HIV, obesity | LM: focal (<50% glomeruli) and segmental sclerosis; EM: foot process effacement; IF: IgM, C3 in sclerotic areas |
| Membranous Nephropathy (MN) | Most common in white adults, insidious onset, high thrombosis risk, anti-PLA₂R+ in 70% | Adults >40, male predominance | LM: GBM thickening, "spike and dome" pattern; EM: subepithelial deposits; IF: granular IgG, C3 |
| Membranoproliferative GN (MPGN) | Mixed nephrotic/nephritic, low complement, can follow infections | Children, young adults | LM: mesangial proliferation, GBM double contour ("tram-track"); IF: C3, IgG; EM: subendothelial deposits |
| C3 Glomerulopathy / Dense Deposit Disease | Complement dysregulation, low C3 | Children | EM: dense intramembranous deposits; IF: C3 dominant |
Secondary Causes
| Cause | Associated Disease | Notes |
|---|---|---|
| Diabetic nephropathy | Diabetes mellitus | Most common cause of NS worldwide; Kimmelstiel-Wilson nodules on biopsy |
| Lupus nephritis (Class V) | SLE | Membranous pattern; ANA, anti-dsDNA positive; low C3/C4 |
| Amyloidosis | AL (multiple myeloma), AA (chronic inflammation: RA, FMF, TB) | Congo red stain → apple-green birefringence; SPEP/UPEP |
| Viral infections | HBV (MN), HCV (MPGN), HIV (collapsing FSGS) | Screen all adults |
| Parasitic infections | Malaria (Plasmodium malariae → MPGN) | Tropical regions |
| Drugs | NSAIDs (MCD/MN), gold, penicillamine, captopril, heroin (FSGS) | Drug history essential |
| Malignancy | Solid tumors → MN; lymphoma (Hodgkin's) → MCD | Paraneoplastic; age >60 |
| Pre-eclampsia | Pregnancy | New-onset proteinuria + hypertension after 20 weeks |
| Hereditary | Alport syndrome, Congenital NS (Finnish type, NPHS1 mutation) | Family history, onset in infancy |
6. Complications
| Complication | Mechanism |
|---|---|
| Thromboembolism | Loss of antithrombin III, proteins C and S; renal vein thrombosis (especially MN) |
| Infections | Loss of IgG, complement; SBP, cellulitis, pneumococcal infections |
| AKI | Volume depletion, NSAID use, renal vein thrombosis, interstitial edema |
| Protein malnutrition | Chronic albumin loss |
| CKD progression | Especially FSGS, MN |
| Cardiovascular disease | Accelerated atherosclerosis from hyperlipidemia |
| Vitamin D deficiency | Loss of vitamin D-binding protein → hypocalcemia, bone disease |
| Hypothyroidism | Loss of thyroid-binding globulin (TBG) → low total T4 (free T4 normal) |
7. Management
General Measures
- Low-sodium diet (< 2 g/day) — reduces edema
- Fluid restriction — if severe edema/hyponatremia
- Moderate protein intake — 0.8–1 g/kg/day (high protein worsens proteinuria)
- Statin therapy — for hyperlipidemia (cardiovascular risk reduction)
- Anticoagulation — if serum albumin < 2 g/dL, or active thrombosis (especially in MN)
- Pneumococcal vaccination — due to infection risk
Diuretics (Edema)
- Loop diuretics (furosemide) — first-line; may need IV due to gut edema impairing oral absorption
- Add thiazide or spironolactone for resistant edema
- Albumin infusion + furosemide for refractory cases
RAAS Blockade (Antiproteinuric)
- ACE inhibitors or ARBs — reduce intraglomerular pressure and proteinuria regardless of BP
Disease-Specific Treatment
| Disease | Treatment |
|---|---|
| MCD | Corticosteroids (prednisone) — >90% remission; relapse common; cyclophosphamide/calcineurin inhibitors for frequent relapsers |
| FSGS | High-dose steroids; calcineurin inhibitors (tacrolimus, cyclosporine) for steroid-resistant; sparsentan (novel dual AT1/endothelin receptor antagonist) |
| Membranous Nephropathy | Rituximab (anti-CD20, targets B cells producing anti-PLA₂R) — now first-line for immunotherapy; cyclosporine; cyclophosphamide + steroids (Ponticelli regimen) |
| Lupus Nephritis Class V | Hydroxychloroquine + RAAS blockade; immunosuppression for concurrent proliferative lesions |
| Diabetic Nephropathy | Strict glycemic control, RAAS blockade, SGLT2 inhibitors (empagliflozin, dapagliflozin) — reduce proteinuria and slow progression |
Nephrotic vs. Nephritic Syndrome — Key Differences
These two syndromes represent fundamentally different types of glomerular injury:
| Feature | Nephrotic Syndrome | Nephritic Syndrome |
|---|---|---|
| Primary defect | Loss of glomerular charge/size selectivity → protein leak | Glomerular inflammation → breach of GBM → blood in urine |
| Proteinuria | Massive: > 3.5 g/day | Mild-moderate: < 3.5 g/day |
| Hematuria | Absent or microscopic | Prominent; RBC casts (pathognomonic) |
| Edema | Severe, generalized (periorbital, ascites, pleural effusion) | Mild-moderate |
| Hypertension | Uncommon in primary NS | Common (Na+ and water retention) |
| Oliguria | Absent unless AKI | Common (↓ GFR) |
| Hypoalbuminemia | Prominent (< 3.5 g/dL) | Mild or absent |
| Hyperlipidemia/lipiduria | Present | Absent |
| GFR/renal function | Initially preserved | Often reduced (azotemia) |
| Urine sediment | Fatty casts, oval fat bodies, Maltese crosses | RBC casts, granular casts, dysmorphic RBCs |
| Complement | Normal (MCD, FSGS, MN) or low (MPGN) | Low in post-streptococcal GN, MPGN, lupus |
| Mechanism | Podocyte injury → permeability defect | Immune complex deposition → inflammation → endocapillary proliferation |
Causes of Nephritic Syndrome (for comparison)
| Disease | Key Features |
|---|---|
| Post-streptococcal GN | Children; 2–3 weeks after strep pharyngitis/skin infection; low C3; granular "starry sky" IF |
| IgA Nephropathy (Berger's) | Most common GN worldwide; hematuria after URI (synpharyngitic); mesangial IgA deposits |
| Lupus Nephritis (Class III/IV) | Proliferative; low C3/C4; "full house" IF pattern (IgG, IgA, IgM, C3, C1q) |
| Anti-GBM Disease (Goodpasture's) | Pulmonary hemorrhage + nephritis; linear IgG on IF; anti-GBM antibodies |
| ANCA-associated Vasculitis | Pauci-immune GN (no/few immune deposits); MPO-ANCA or PR3-ANCA; crescentic GN |
| MPGN | Can present as nephritic or nephrotic or mixed; low C3 |
Mixed Presentations
Some diseases can present with features of both syndromes:
- MPGN — heavy proteinuria + hematuria + low complement
- Lupus nephritis (Class III/IV/V) — especially Class IV (diffuse proliferative) with nephrotic-range proteinuria
- Diabetic nephropathy — usually pure nephrotic, but can have microhematuria
Mnemonic: Nephrotic vs. Nephritic
NephROTic = ROT (protein ROTs away) Protein loss, frothy urine, edema, lipid abnormalities, no blood
NephRITic = RITIS (as in nephRITIS/inflammation) Blood, RBC casts, hypertension, oliguria, ↓ GFR
Sources: Harrison's Principles of Internal Medicine, 21st Edition, pp. 1376, 8392, 8394
This is a shared conversation. Sign in to Orris to start your own chat.